Effects of intervention on use of troxerutin cerebroprotein hydrolysate injection by clinical pharmacists in combination with other departments
CHEN Ji-zhi
LI Gang
XU Xiao-yan
YANG Yang
WU Jun
Abstract：Objective: To investigate the effect of intervention on use of troxerutin cerebroprotein hydrolysate injection by clinical pharmacists and other surgical departments of our hospital. Methods: Data of the patients treated with troxerutin cerebroprotein hydrolysate injection in our hospital from July 2017 to October 2017 was collected and retrospectively analyzed focusing on the amount of troxerutin cerebroprotein hydrolysate injection and rationality before and after intervention. Results: The amount of troxerutin cerebroprotein hydrolysate injection and the number of patients who used troxerutin cerebroprotein hydrolysate injection were obviously reduced after intervention, among all the key monitoring drugs, the cost ratio of troxerutin cerebroprotein hydrolysate dropped from 9.87% to 1.78%. The ratio of rational drug use of troxerutin cerebroprotein hydrolysate increased from 41.8% before intervention to 90.5% after intervention and there were significant differences between them (P < 0.01). The ratio of unreasonalbe time of drug use dropped from 32.68% before intervention to 6.52% after intervention (P < 0.01) and ratio of unreasonable drug combination dropped from 28.10% before intervention to 4.76% after intervention (P < 0.01). Conclusion:Clinical pharmacist's intervention together with other departments could obviously improve the rational use of troxerutin cerebroprotein hydrolysate injection, which could provide good foundation for the key drug monitoring.
Keywords：Troxerutin cerebroprotein hydrolysateClinical pharmacistCombined interventionsKey monitoring drugEffect
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 102-105 )